Cecilia Chambers


Cecilia Chambers is currently undertaking a PhD candidature in the Invasion and Metastasis group under Prof. Paul Timpson at the Garvan Institute of Medical Research. Her research sits within the T1/T2 end of the translational spectrum and is focussed on investigating the efficacy of inhibiting the Neuropeptide Y (NPY) signalling axis as a novel therapeutic strategy in Pancreatic Cancer. She uses a number of short-term in-vitro and in-vivo murine models alongside longer-term survival studies to elucidate the role NPY plays in pancreatic cancer progression and thus hopes to finetune the manipulation of this signalling pathway with the ultimate goal of identifying  a novel therapeutic option for patients suffering from this devastating disease.